Nanosecond pulsed electric field (nsPEF) and vaccines: a novel technique for the inactivation of SARS-CoV-2 and other viruses?
Since the beginning of 2020, worldwide attention has been focused on SARS-CoV-2, the second strain of the severe acute respiratory syndrome virus. Although advances in vaccine technology have been made, particularly considering the advent of mRNA vaccines, up to date, no single antigen design can en...
Saved in:
Published in: | Annals of medicine (Helsinki) Vol. 54; no. 1; pp. 1749 - 1756 |
---|---|
Main Authors: | , , |
Format: | Journal Article |
Language: | English |
Published: |
Taylor & Francis
31-12-2022
Taylor & Francis Group |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Since the beginning of 2020, worldwide attention has been focused on SARS-CoV-2, the second strain of the severe acute respiratory syndrome virus. Although advances in vaccine technology have been made, particularly considering the advent of mRNA vaccines, up to date, no single antigen design can ensure optimal immune response. Therefore, new technologies must be tested as to their ability to further improve vaccines. Nanosecond Pulsed Electric Field (nsPEF) is one such method showing great promise in different biomedical and industrial fields, including the fight against COVID-19. Of note, available research shows that nsPEF directly damages the cell's DNA, so it is critical to determine if this technology could be able to fragment either viral DNA or RNA so as to be used as a novel technology to produce inactivated pathogenic agents that may, in turn, be used for the production of vaccines. Considering the available evidence, we propose that nsPEF may be used to produce inactivated SARS-CoV-2 viruses that may in turn be used to produce novel vaccines, as another tool to address 20 the current COVID-19 pandemic.
Key Messages
Viral inactivation by using pulsed electric fields in the nanosecond frequency.
DNA fragmentation by a Nanosecond Pulsed Electric Field (nsPEF).
Opportunity to apply new technologies in vaccine development. |
---|---|
AbstractList | Since the beginning of 2020, worldwide attention has been focused on SARS-CoV-2, the second strain of the severe acute respiratory syndrome virus. Although advances in vaccine technology have been made, particularly considering the advent of mRNA vaccines, up to date, no single antigen design can ensure optimal immune response. Therefore, new technologies must be tested as to their ability to further improve vaccines. Nanosecond Pulsed Electric Field (nsPEF) is one such method showing great promise in different biomedical and industrial fields, including the fight against COVID-19. Of note, available research shows that nsPEF directly damages the cell’s DNA, so it is critical to determine if this technology could be able to fragment either viral DNA or RNA so as to be used as a novel technology to produce inactivated pathogenic agents that may, in turn, be used for the production of vaccines. Considering the available evidence, we propose that nsPEF may be used to produce inactivated SARS-CoV-2 viruses that may in turn be used to produce novel vaccines, as another tool to address 20 the current COVID-19 pandemic.Key MessagesViral inactivation by using pulsed electric fields in the nanosecond frequency.DNA fragmentation by a Nanosecond Pulsed Electric Field (nsPEF).Opportunity to apply new technologies in vaccine development. Since the beginning of 2020, worldwide attention has been focused on SARS-CoV-2, the second strain of the severe acute respiratory syndrome virus. Although advances in vaccine technology have been made, particularly considering the advent of mRNA vaccines, up to date, no single antigen design can ensure optimal immune response. Therefore, new technologies must be tested as to their ability to further improve vaccines. Nanosecond Pulsed Electric Field (nsPEF) is one such method showing great promise in different biomedical and industrial fields, including the fight against COVID-19. Of note, available research shows that nsPEF directly damages the cell's DNA, so it is critical to determine if this technology could be able to fragment either viral DNA or RNA so as to be used as a novel technology to produce inactivated pathogenic agents that may, in turn, be used for the production of vaccines. Considering the available evidence, we propose that nsPEF may be used to produce inactivated SARS-CoV-2 viruses that may in turn be used to produce novel vaccines, as another tool to address 20 the current COVID-19 pandemic. Key Messages Viral inactivation by using pulsed electric fields in the nanosecond frequency. DNA fragmentation by a Nanosecond Pulsed Electric Field (nsPEF). Opportunity to apply new technologies in vaccine development. Since the beginning of 2020, worldwide attention has been being focussed on SARS-CoV-2, the second strain of the severe acute respiratory syndrome virus. Although advances in vaccine technology have been made, particularly considering the advent of mRNA vaccines, up to date, no single antigen design can ensure optimal immune response. Therefore, new technologies must be tested as to their ability to further improve vaccines. Nanosecond Pulsed Electric Field (nsPEF) is one such method showing great promise in different biomedical and industrial fields, including the fight against COVID-19. Of note, available research shows that nsPEF directly damages the cell’s DNA, so it is critical to determine if this technology could be able to fragment either viral DNA or RNA so as to be used as a novel technology to produce inactivated pathogenic agents that may, in turn, be used for the production of vaccines. Considering the available evidence, we propose that nsPEF may be used to produce inactivated SARS-CoV-2 viruses that may in turn be used to produce novel vaccines, as another tool to address 20 the current COVID-19 pandemic. Key Messages Viral inactivation by using pulsed electric fields in the nanosecond frequency. DNA fragmentation by a Nanosecond Pulsed Electric Field (nsPEF). Opportunity to apply new technologies in vaccine development. |
Author | Rosemblatt, M. Ruiz-Fernández, A. R. Perez-Acle, T. |
Author_xml | – sequence: 1 givenname: A. R. surname: Ruiz-Fernández fullname: Ruiz-Fernández, A. R. organization: Facultad de Ingeniería y Tecnología, Universidad San Sebastián – sequence: 2 givenname: M. surname: Rosemblatt fullname: Rosemblatt, M. organization: Facultad de Medicina y Ciencia, Universidad San Sebastián – sequence: 3 givenname: T. surname: Perez-Acle fullname: Perez-Acle, T. organization: Facultad de Ingeniería y Tecnología, Universidad San Sebastián |
BookMark | eNp9kkFvFCEUx4lpY7fVj2DCsR6mAjMMjAe12bTapFFj1St5A2-6NLOwwuyaXvzsst21SS9egMCP3wu8_zE5CDEgIa84O-NMszdMaVnrjp0JJkQZtNKdfkZmvG5lJVjLDshsy1Rb6Igc53zHGBOKs-fkqJZKt1yqGfnzGULMaGNwdLUeMzqKI9opeUsHj6OjpyF_vbh8TaEQG7DWB8xvKdAQNzjSCe0i-F9rpENMdFog9QHs5Dcw-RhoHOjN-bebah5_VuJBEQuT6Mandcb8_gU5HKBUfbmfT8iPy4vv80_V9ZePV_Pz68o2DZ8qJ2TnuOKuUcCUbblqGtFDpx1vu7LoBy0A-6Z36ISVCnrV1axWygloVSfrE3K187oId2aV_BLSvYngzcNGTLcG0uTtiAZbzQYOWmrZN2oA4B1q5NZJyRWzrrje7Vyrdb9EZzFMCcYn0qcnwS_MbdyYTkhdGlMEp3tBiuXn8mSWPlscRwgY19mIVktWi_KAgsodalPMOeHwWIYzs82B-ZcDs82B2eeg3Puwu-dD6csSfsc0OjPB_RjTkCBYn039f8Vfh7-6zw |
CitedBy_id | crossref_primary_10_3390_ijms241411397 crossref_primary_10_3390_ijms24054673 crossref_primary_10_1186_s13568_023_01601_3 crossref_primary_10_3390_ijms24119191 |
Cites_doi | 10.1016/j.bioelechem.2017.09.003 10.1002/ijc.31071 10.1016/j.bbrc.2004.03.063 10.1016/j.bbrc.2011.04.056 10.1016/j.bioelechem.2014.08.014 10.1109/IAS.1990.152263 10.1007/978-1-4939-2438-7_1 10.1016/j.abb.2010.03.008 10.1016/j.bpj.2008.11.011 10.1371/journal.pone.0191311 10.1016/j.bioelechem.2015.05.013 10.1186/s40425-017-0234-5 10.1117/1.JBO.18.3.035005 10.1074/jbc.M311135200 10.1109/CEIDP.2002.1048741 10.1007/s00232-010-9269-y 10.1109/TPS.2002.1003872 10.1109/MELECON48756.2020.9140604 10.1016/0005-2736(88)90068-5 10.1016/j.bbrc.2009.05.035 10.1109/TDEI.2009.5293940 10.1109/PLASMA.2017.8496052 10.1038/srep25949 10.3390/app10124244 10.1371/journal.pone.0196688 10.1096/fj.02-0859fje 10.1016/j.bbrc.2013.05.039 10.1016/j.ifset.2018.04.013 10.1007/s10495-007-0083-7 10.1016/j.ejca.2014.07.006 10.1038/srep05836 10.1016/j.biortech.2020.124173 10.1002/bem.20354 10.1109/MODSYM.1996.564454 10.1016/j.bbamem.2018.08.017 10.1016/S0006-3495(88)83181-3 10.14814/phy2.12461 10.1016/j.bbamem.2017.07.004 10.1093/cercor/6.2.93 10.1074/jbc.M117.803049 10.1021/jp309857b 10.1016/j.bbamem.2014.06.015 10.1088/0967-3334/25/4/023 10.1201/EBK1439819067 10.1016/j.str.2020.10.001 10.1109/PPC.1997.679279 10.1109/MSMW.2016.7537992 10.1038/d41573-020-00073-5 10.1089/104454903322624993 10.3390/cells2010136 10.1155/2018/9046891 10.1371/journal.pone.0134364 10.1016/S0022-0728(80)80278-6 10.1016/j.bbrc.2019.08.133 10.1016/j.bbamem.2017.04.016 10.1051/ject/201244198 10.1073/pnas.0830918100 10.1016/j.bioelechem.2012.02.007 10.1007/s10495-010-0572-y 10.1111/j.1755-148X.2012.01027.x 10.1080/07391102.2020.1761882 10.1016/j.bbagen.2010.07.008 10.1002/bem.71 10.1016/j.abb.2007.12.009 10.1038/s41598-018-26521-2 10.1111/j.1755-148X.2010.00704.x 10.1007/s10495-014-1041-9 10.1038/mtm.2014.43 10.1016/j.bioelechem.2016.02.011 10.1002/ppap.201400131 10.1016/j.bioelechem.2008.02.003 10.1016/j.biortech.2018.09.124 10.1111/jce.13834 10.1098/rsif.2019.0079 10.1111/tmi.13383 10.1016/j.bioelechem.2018.06.009 10.1016/j.bbrc.2006.01.094 10.3390/membranes11070473 10.1038/s41598-019-47929-4 10.1016/j.elstat.2012.06.004 10.1007/s00436-017-5412-3 10.1016/j.mrgentox.2003.08.006 10.1007/s00709-020-01534-9 10.1007/s10571-010-9573-1 10.1016/j.bbamem.2012.11.032 10.1016/S0921-8777(00)00041-0 10.1109/TDEI.2009.5293945 10.1109/PLASMA.2003.1230010 10.1201/EBK1439819067-14 10.1016/j.ijheh.2006.06.004 10.1007/s00232-001-0084-3 10.1007/s12032-016-0882-1 10.1016/j.mehy.2020.110259 10.1038/s41598-017-10282-5 10.1016/0022-0728(91)85564-6 10.1016/j.bpj.2020.05.030 10.1038/s41598-019-56635-0 10.1109/IPMC.2008.4743579 10.1109/TPS.2004.831758 |
ContentType | Journal Article |
Copyright | 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 The Author(s) |
Copyright_xml | – notice: 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 – notice: 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 The Author(s) |
DBID | 0YH AAYXX CITATION 7X8 5PM DOA |
DOI | 10.1080/07853890.2022.2087898 |
DatabaseName | Taylor & Francis Open Access Journals CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | A. R. Ruiz-Fernández et al |
EISSN | 1365-2060 |
EndPage | 1756 |
ExternalDocumentID | oai_doaj_org_article_e680f1a8585b47faa19e8e1cd55170cd 10_1080_07853890_2022_2087898 2087898 |
Genre | Infectious Diseases |
GroupedDBID | --- 00X 03L 0R~ 0YH 23M 36B 4.4 5GY 5RE AAJNR AALUX AAPXX ABBKH ABLKL ABUPF ACENM ACFUF ACGEJ ACGFS ADCVX ADFCX ADRBQ ADXPE AENEX AEOZL AEYQI AFKVX AIJEM AIRBT AJWEG ALIIL ALMA_UNASSIGNED_HOLDINGS BABNJ BLEHA BOHLJ CCCUG CS3 CYYVM DKSSO EBD EBS EMB EMOBN F5P GROUPED_DOAJ HZ~ KRBQP KSSTO KWAYT KYCEM LJTGL M4Z O9- OK1 P2P RPM SV3 TFDNU TFL TFW V1S WH7 ~1N AAYXX AGYJP CITATION H13 TDBHL 7X8 5PM |
ID | FETCH-LOGICAL-c441t-d259d171d47a07c617442ba98d1692babf82aeb4bded2c57ab7930377d2a67953 |
IEDL.DBID | RPM |
ISSN | 0785-3890 |
IngestDate | Tue Oct 22 15:09:27 EDT 2024 Tue Sep 17 20:42:29 EDT 2024 Fri Oct 25 06:53:15 EDT 2024 Wed Nov 27 12:55:16 EST 2024 Tue Jun 13 19:24:41 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | open-access: http://creativecommons.org/licenses/by-nc/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c441t-d259d171d47a07c617442ba98d1692babf82aeb4bded2c57ab7930377d2a67953 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258060/ |
PMID | 35786157 |
PQID | 2685032303 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_e680f1a8585b47faa19e8e1cd55170cd crossref_primary_10_1080_07853890_2022_2087898 informaworld_taylorfrancis_310_1080_07853890_2022_2087898 proquest_miscellaneous_2685032303 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9258060 |
PublicationCentury | 2000 |
PublicationDate | 2022-12-31 |
PublicationDateYYYYMMDD | 2022-12-31 |
PublicationDate_xml | – month: 12 year: 2022 text: 2022-12-31 day: 31 |
PublicationDecade | 2020 |
PublicationTitle | Annals of medicine (Helsinki) |
PublicationYear | 2022 |
Publisher | Taylor & Francis Taylor & Francis Group |
Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Group |
References | e_1_3_5_27_1 e_1_3_5_100_1 e_1_3_5_23_1 e_1_3_5_46_1 e_1_3_5_69_1 e_1_3_5_88_1 e_1_3_5_104_1 e_1_3_5_61_1 e_1_3_5_80_1 Chen X (e_1_3_5_53_1) 2017; 7 e_1_3_5_42_1 e_1_3_5_65_1 e_1_3_5_84_1 e_1_3_5_9_1 e_1_3_5_5_1 e_1_3_5_39_1 e_1_3_5_16_1 e_1_3_5_35_1 e_1_3_5_12_1 e_1_3_5_77_1 e_1_3_5_58_1 e_1_3_5_50_1 e_1_3_5_92_1 e_1_3_5_73_1 e_1_3_5_96_1 e_1_3_5_31_1 e_1_3_5_101_1 e_1_3_5_24_1 e_1_3_5_66_1 e_1_3_5_47_1 e_1_3_5_89_1 e_1_3_5_105_1 e_1_3_5_81_1 e_1_3_5_62_1 e_1_3_5_43_1 e_1_3_5_85_1 e_1_3_5_8_1 e_1_3_5_20_1 e_1_3_5_4_1 Long G (e_1_3_5_79_1) 2014; 13 e_1_3_5_17_1 e_1_3_5_13_1 e_1_3_5_36_1 e_1_3_5_55_1 e_1_3_5_78_1 e_1_3_5_59_1 e_1_3_5_70_1 e_1_3_5_93_1 e_1_3_5_51_1 e_1_3_5_74_1 e_1_3_5_97_1 e_1_3_5_32_1 e_1_3_5_29_1 e_1_3_5_102_1 e_1_3_5_25_1 e_1_3_5_67_1 e_1_3_5_48_1 Marracino P (e_1_3_5_87_1) 2013; 3 e_1_3_5_106_1 e_1_3_5_82_1 e_1_3_5_3_1 e_1_3_5_40_1 e_1_3_5_63_1 e_1_3_5_86_1 e_1_3_5_21_1 Zhang Y (e_1_3_5_28_1) 2018; 13 e_1_3_5_7_1 e_1_3_5_18_1 e_1_3_5_37_1 e_1_3_5_14_1 e_1_3_5_33_1 e_1_3_5_56_1 e_1_3_5_94_1 e_1_3_5_71_1 e_1_3_5_52_1 e_1_3_5_98_1 e_1_3_5_75_1 e_1_3_5_10_1 e_1_3_5_90_1 e_1_3_5_26_1 e_1_3_5_22_1 e_1_3_5_45_1 e_1_3_5_107_1 e_1_3_5_68_1 e_1_3_5_49_1 e_1_3_5_103_1 e_1_3_5_83_1 e_1_3_5_2_1 e_1_3_5_60_1 e_1_3_5_41_1 e_1_3_5_64_1 e_1_3_5_6_1 Hargrave B (e_1_3_5_44_1) 2012; 44 e_1_3_5_38_1 e_1_3_5_15_1 e_1_3_5_11_1 e_1_3_5_34_1 e_1_3_5_57_1 e_1_3_5_99_1 Chen X (e_1_3_5_54_1) 2018; 2018 e_1_3_5_19_1 e_1_3_5_72_1 e_1_3_5_91_1 e_1_3_5_76_1 e_1_3_5_95_1 e_1_3_5_30_1 |
References_xml | – ident: e_1_3_5_19_1 doi: 10.1016/j.bioelechem.2017.09.003 – ident: e_1_3_5_59_1 doi: 10.1002/ijc.31071 – volume: 2018 start-page: 1 year: 2018 ident: e_1_3_5_54_1 article-title: Experimental nanopulse ablation of multiple membrane parasite on ex vivo hydatid cyst publication-title: Biomed Res Int contributor: fullname: Chen X – ident: e_1_3_5_71_1 doi: 10.1016/j.bbrc.2004.03.063 – ident: e_1_3_5_47_1 doi: 10.1016/j.bbrc.2011.04.056 – ident: e_1_3_5_84_1 doi: 10.1016/j.bioelechem.2014.08.014 – ident: e_1_3_5_85_1 doi: 10.1109/IAS.1990.152263 – ident: e_1_3_5_93_1 doi: 10.1007/978-1-4939-2438-7_1 – ident: e_1_3_5_22_1 doi: 10.1016/j.abb.2010.03.008 – ident: e_1_3_5_39_1 doi: 10.1016/j.bpj.2008.11.011 – ident: e_1_3_5_60_1 doi: 10.1371/journal.pone.0191311 – ident: e_1_3_5_10_1 doi: 10.1016/j.bioelechem.2015.05.013 – ident: e_1_3_5_58_1 doi: 10.1186/s40425-017-0234-5 – ident: e_1_3_5_35_1 doi: 10.1117/1.JBO.18.3.035005 – ident: e_1_3_5_16_1 doi: 10.1074/jbc.M311135200 – ident: e_1_3_5_72_1 doi: 10.1109/CEIDP.2002.1048741 – volume: 13 start-page: 561 issue: 6 year: 2014 ident: e_1_3_5_79_1 article-title: Histological and finite element analysis of cell death due to irreversible electroporation publication-title: Technol Cancer Res Treat contributor: fullname: Long G – ident: e_1_3_5_103_1 doi: 10.1007/s00232-010-9269-y – ident: e_1_3_5_4_1 doi: 10.1109/TPS.2002.1003872 – ident: e_1_3_5_38_1 doi: 10.1109/MELECON48756.2020.9140604 – ident: e_1_3_5_63_1 – volume: 3 start-page: 2161 issue: 02 year: 2013 ident: e_1_3_5_87_1 article-title: Technology of high-intensity electric-field pulses: a way to control protein unfolding publication-title: J Phys Chem Biophys contributor: fullname: Marracino P – ident: e_1_3_5_96_1 doi: 10.1016/0005-2736(88)90068-5 – ident: e_1_3_5_100_1 doi: 10.1016/j.bbrc.2009.05.035 – ident: e_1_3_5_75_1 doi: 10.1109/TDEI.2009.5293940 – ident: e_1_3_5_27_1 doi: 10.1109/PLASMA.2017.8496052 – ident: e_1_3_5_61_1 doi: 10.1038/srep25949 – ident: e_1_3_5_107_1 doi: 10.3390/app10124244 – volume: 13 start-page: e0196688 issue: 5 year: 2018 ident: e_1_3_5_28_1 article-title: Nanosecond pulsed electric fields promoting the proliferation of porcine iliac endothelial cells: an in vitro study publication-title: PLOS One doi: 10.1371/journal.pone.0196688 contributor: fullname: Zhang Y – ident: e_1_3_5_5_1 doi: 10.1096/fj.02-0859fje – ident: e_1_3_5_77_1 doi: 10.1016/j.bbrc.2013.05.039 – ident: e_1_3_5_64_1 doi: 10.1016/j.ifset.2018.04.013 – ident: e_1_3_5_21_1 doi: 10.1007/s10495-007-0083-7 – ident: e_1_3_5_56_1 doi: 10.1016/j.ejca.2014.07.006 – ident: e_1_3_5_48_1 doi: 10.1038/srep05836 – ident: e_1_3_5_65_1 doi: 10.1016/j.biortech.2020.124173 – ident: e_1_3_5_98_1 doi: 10.1002/bem.20354 – ident: e_1_3_5_2_1 doi: 10.1109/MODSYM.1996.564454 – ident: e_1_3_5_14_1 doi: 10.1016/j.bbamem.2018.08.017 – ident: e_1_3_5_97_1 doi: 10.1016/S0006-3495(88)83181-3 – ident: e_1_3_5_45_1 doi: 10.14814/phy2.12461 – volume: 7 start-page: 1 issue: 1 year: 2017 ident: e_1_3_5_53_1 article-title: Novel interventional management of hepatic hydatid cyst with nanosecond pulses on experimental mouse model publication-title: Sci Rep contributor: fullname: Chen X – ident: e_1_3_5_11_1 doi: 10.1016/j.bbamem.2017.07.004 – ident: e_1_3_5_81_1 doi: 10.1093/cercor/6.2.93 – ident: e_1_3_5_51_1 doi: 10.1074/jbc.M117.803049 – ident: e_1_3_5_86_1 doi: 10.1021/jp309857b – ident: e_1_3_5_17_1 doi: 10.1016/j.bbamem.2014.06.015 – ident: e_1_3_5_46_1 doi: 10.1088/0967-3334/25/4/023 – ident: e_1_3_5_101_1 doi: 10.1201/EBK1439819067 – ident: e_1_3_5_90_1 doi: 10.1016/j.str.2020.10.001 – ident: e_1_3_5_31_1 doi: 10.1109/PPC.1997.679279 – ident: e_1_3_5_36_1 doi: 10.1109/MSMW.2016.7537992 – ident: e_1_3_5_92_1 doi: 10.1038/d41573-020-00073-5 – ident: e_1_3_5_74_1 doi: 10.1089/104454903322624993 – ident: e_1_3_5_25_1 doi: 10.3390/cells2010136 – ident: e_1_3_5_13_1 doi: 10.1155/2018/9046891 – ident: e_1_3_5_57_1 doi: 10.1371/journal.pone.0134364 – ident: e_1_3_5_95_1 doi: 10.1016/S0022-0728(80)80278-6 – ident: e_1_3_5_42_1 doi: 10.1016/j.bbrc.2019.08.133 – ident: e_1_3_5_12_1 doi: 10.1016/j.bbamem.2017.04.016 – volume: 44 start-page: 198 issue: 4 year: 2012 ident: e_1_3_5_44_1 article-title: Nanosecond pulse electric field activation of platelet-rich plasma reduces myocardial infarct size and improves left ventricular mechanical function in the rabbit heart publication-title: J Extra Corpor Technol doi: 10.1051/ject/201244198 contributor: fullname: Hargrave B – ident: e_1_3_5_105_1 doi: 10.1073/pnas.0830918100 – ident: e_1_3_5_80_1 doi: 10.1016/j.bioelechem.2012.02.007 – ident: e_1_3_5_24_1 doi: 10.1007/s10495-010-0572-y – ident: e_1_3_5_55_1 doi: 10.1111/j.1755-148X.2012.01027.x – ident: e_1_3_5_89_1 doi: 10.1080/07391102.2020.1761882 – ident: e_1_3_5_104_1 doi: 10.1016/j.bbagen.2010.07.008 – ident: e_1_3_5_33_1 doi: 10.1002/bem.71 – ident: e_1_3_5_7_1 doi: 10.1016/j.abb.2007.12.009 – ident: e_1_3_5_40_1 doi: 10.1038/s41598-018-26521-2 – ident: e_1_3_5_23_1 doi: 10.1111/j.1755-148X.2010.00704.x – ident: e_1_3_5_50_1 doi: 10.1007/s10495-014-1041-9 – ident: e_1_3_5_49_1 doi: 10.1038/mtm.2014.43 – ident: e_1_3_5_3_1 doi: 10.1016/j.bioelechem.2016.02.011 – ident: e_1_3_5_68_1 doi: 10.1002/ppap.201400131 – ident: e_1_3_5_99_1 doi: 10.1016/j.bioelechem.2008.02.003 – ident: e_1_3_5_29_1 doi: 10.1016/j.biortech.2018.09.124 – ident: e_1_3_5_41_1 doi: 10.1111/jce.13834 – ident: e_1_3_5_30_1 doi: 10.1098/rsif.2019.0079 – ident: e_1_3_5_88_1 doi: 10.1111/tmi.13383 – ident: e_1_3_5_18_1 doi: 10.1016/j.bioelechem.2018.06.009 – ident: e_1_3_5_34_1 doi: 10.1016/j.bbrc.2006.01.094 – ident: e_1_3_5_83_1 doi: 10.3390/membranes11070473 – ident: e_1_3_5_15_1 doi: 10.1038/s41598-019-47929-4 – ident: e_1_3_5_20_1 doi: 10.1109/TPS.2002.1003872 – ident: e_1_3_5_67_1 doi: 10.1016/j.elstat.2012.06.004 – ident: e_1_3_5_52_1 doi: 10.1007/s00436-017-5412-3 – ident: e_1_3_5_73_1 doi: 10.1016/j.mrgentox.2003.08.006 – ident: e_1_3_5_62_1 doi: 10.1007/s00709-020-01534-9 – ident: e_1_3_5_8_1 doi: 10.1007/s10571-010-9573-1 – ident: e_1_3_5_9_1 doi: 10.1016/j.bbamem.2012.11.032 – ident: e_1_3_5_76_1 doi: 10.1016/S0921-8777(00)00041-0 – ident: e_1_3_5_66_1 doi: 10.1109/TDEI.2009.5293945 – ident: e_1_3_5_70_1 doi: 10.1109/PLASMA.2003.1230010 – ident: e_1_3_5_102_1 doi: 10.1201/EBK1439819067-14 – ident: e_1_3_5_106_1 doi: 10.1016/j.ijheh.2006.06.004 – ident: e_1_3_5_32_1 doi: 10.1007/s00232-001-0084-3 – ident: e_1_3_5_26_1 doi: 10.1007/s12032-016-0882-1 – ident: e_1_3_5_69_1 doi: 10.1016/j.mehy.2020.110259 – ident: e_1_3_5_37_1 doi: 10.1038/s41598-017-10282-5 – ident: e_1_3_5_94_1 doi: 10.1016/0022-0728(91)85564-6 – ident: e_1_3_5_82_1 doi: 10.1016/j.bpj.2020.05.030 – ident: e_1_3_5_78_1 doi: 10.1038/s41598-019-56635-0 – ident: e_1_3_5_43_1 doi: 10.1109/IPMC.2008.4743579 – ident: e_1_3_5_6_1 doi: 10.1109/TPS.2004.831758 – ident: e_1_3_5_91_1 |
SSID | ssj0002710 |
Score | 2.4458492 |
Snippet | Since the beginning of 2020, worldwide attention has been focused on SARS-CoV-2, the second strain of the severe acute respiratory syndrome virus. Although... Since the beginning of 2020, worldwide attention has been being focussed on SARS-CoV-2, the second strain of the severe acute respiratory syndrome virus.... |
SourceID | doaj pubmedcentral proquest crossref informaworld |
SourceType | Open Website Open Access Repository Aggregation Database Publisher |
StartPage | 1749 |
SubjectTerms | Infectious Diseases NPS nsPEF SARS-CoV-2 vaccines |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nj9QgFCe6B-PF-BlHV4OJBz2glFIeeDHrOpO9aIyjxhuhQLOTmHaznZnj_u0-aDvZetmLt4bS5sF7vA_g_R4hrxUE1PxSMhULxaRxipnSeMa5Q3mKEnidAsWzNXz9rT8vE0zOodRXuhM2wAMPE_c-Ks2bwqXjq1pC41xhoo6FD2jqgfuQtS9XUzA16mABGYcA7V_F0CTzKXcnoWpjW2rC2FCkTCwN2uiZVcrg_f9Al84c0Pn1yWv2aHWf3BsdSXoyDOABuRXbh-TOl_Go_BG5Qr3Z9SncDfRihwYw0KHkzcbTfG2Nvmn7b8vVW-qwx9759Fn_gTradvv4hx7AXSmSR9FNpJs2JUEMW7i0a-j65PuanXa_mMi_yKlcdL-53PWx__iY_Fwtf5yesbHYAvPoEW1ZwDgoFFAECY6DR8dGSlE7o0OhDD7UjRYu1rIOMQhfgatxZfMSIAinwFTlE3LUdm18SqjxldARoIlRyKBqF72uKqghgdurqlyQd9Nk24sBU8MWE1TpyB2buGNH7izIp8SSQ-cEiZ0bUFDsKCj2JkFZEHOdoXabd0SaoXyJLW8g4NXEfYvLL52puDZ2u94KpSteYhyHo4KZWMyonb9pN-cZyNuISnPFn_2P4T0ndxPFAwblMTnaXu7iC3K7D7uXeWn8BTuhDm4 priority: 102 providerName: Directory of Open Access Journals |
Title | Nanosecond pulsed electric field (nsPEF) and vaccines: a novel technique for the inactivation of SARS-CoV-2 and other viruses? |
URI | https://www.tandfonline.com/doi/abs/10.1080/07853890.2022.2087898 https://search.proquest.com/docview/2685032303 https://pubmed.ncbi.nlm.nih.gov/PMC9258060 https://doaj.org/article/e680f1a8585b47faa19e8e1cd55170cd |
Volume | 54 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELboHhAXxFOUx8pIHODg1nESP7igpbTay6IVBcTNcmwHIu0mVdP0yG9n7CSrDRckbpFjR-PM2DNjz3yD0BsuHOz8WUa4TzjJlOFEpcoSSg3Ik88ELYKjeL4Vn3_IT-sAk5OPuTAxaN8W1aK-ul7U1a8YW7m7tssxTmx5ebFSLJeU0-UMzcA2HF30YftlIkIQgOrLCWhjOqbtBEBtaAtN4BaykIQlhVShYF9AfAHNLia6KUL4_wVgOjFDp0GUt7TS5gG6P5iT-Kwn-yG64-tH6O7FcGH-GP2G3bNpg9Pr8K4DNehwX_imsjgGr-G3dXu53rzDBnocjQ3D2vfY4Lo5-it8A_GKgTwMxiKu6pAK0R_k4qbE27MvW7JqvhMWPxETuvCx2netbz88Qd8266-rczKUXCAW7KIDceANuUQkLhOGCgvmTZaxwijpEq7goSglM77ICucds7kwBaxvmgrhmOFC5elTdFI3tX-GsLI5k16I0nuWOV4Yb2Wei0IEiHuep3O0GH-23vXIGjoZAUsHRunAKD0wao4-BpbcdA7A2LGh2f_Ug3hozyUtExNuO4tMlMYkykufWAeWoaDWzZG6zVB9iOciZV_ERKf_IOD1yH0NizDcrJjaN12rGZc5TcGbg1mJiVhMqJ2-AemOcN6DND__75Ev0L1AZg8_-RKdHPadf4VmretO4xHDaVwgfwDlZw9j |
link.rule.ids | 230,315,729,782,786,866,887,2106,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbYRQIuvBHlaSQOcEjrOIkfXNBSWhWxXa3ogrhZju1ApN2katoe-e2MnWS14YK0t8iPyNaM52HPfIPQW8YtSP40jZiLWZRKzSKZSBMRooGfXMpJ7h3FxYqf_BSfZx4mJ-tzYULQvsnLcXV-Ma7K3yG2cn1hJn2c2OR0OZU0E4SRyQG6CeeVkN5J7wQw5QGEAJRfFoE-Jn3ijofUhjbfBI4h9WlYggvpS_Z5zBfQ7XygnQKI_z8QpgNDdBhGeUUvze9dc0f30d3OEMVHbfcDdMNVD9GtZffU_gj9AblbN95dtni9AwVqcVsypzQ4hL3hd1VzOpu_xxpG7LXx05oPWOOq3rtzfAkOi2FbGMxMXFY-iaK9AsZ1gVdH31bRtP4R0fCLkAqG9-Vm17jm42P0fT47my6irlhDZMCi2kYW_Cgb89imXBNuwDBKU5prKWzMJHzkhaDa5WlunaUm4zoHyUASzi3VjMsseYIOq7pyTxGWJqPCcV44R1PLcu2MyDKecw-Oz7JkhMY9kdS6xeRQcQ912hFYeQKrjsAj9MmT8nKwh9QODfXml-rIoBwTpIi1fyfNU15oHUsnXGws2JScGDtC8iojqG24USna8icq-c8C3vRco-D4-jcZXbl61yjKREYS8ANhV3zAToPVDnuAiwIQeMc1z6498zW6vThbHqvjLydfn6M7fsktiOULdLjd7NxLdNDY3atwvP4CZ6Ij9A |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELbYRVpx4Y22PI3EAQ5pHSfxgwtauq0Wwa4qCoib5dgORNpNqqbtkd_O2EmqDRckuEWObdma8TzsmW8QesW4BcmfphFzMYtSqVkkE2kiQjTwk0s5yb2jeLbkF9_F6czD5OxLfYWgfZOX4-ryalyVP0Ns5erKTPo4scnifCppJggjk5UtJgfoJpxZQntHvRPClAcgAlCAWQQ6mfTJOx5WG9p8EziH1KdiCS6kL9vncV9Av_OBhgpA_n_AmA6M0WEo5TXdNL_zH7u6i253Bik-abvcQzdcdR8dnXdP7g_QL5C_dePdZotXW1CkFrelc0qDQ_gbfl01i9n8DdbQY6eNH9a8xRpX9c5d4j1ILIatYTA3cVn5ZIr2KhjXBV6efF5G0_pbRMMUISUM78r1tnHNu4fo63z2ZXoWdUUbIgOW1Say4E_ZmMc25ZpwAwZSmtJcS2FjJuEjLwTVLk9z6yw1Gdc5SAiScG6pZlxmySN0WNWVO0ZYmowKx3nhHE0ty7UzIst4zj1IPsuSERr3hFKrFptDxT3kaUdk5YmsOiKP0HtPzn1nD60dGur1D9WRQjkmSBFr_16ap7zQOpZOuNhYsC05MXaE5HVmUJtws1K0ZVBU8pcFvOw5R8Ex9m8zunL1tlGUiYwk4A_CrviApQarHf4BTgqA4B3nPP7nkS_Q0eJ0rj59uPj4BN3yK26xLJ-iw816656hg8Zun4cT9huq9CZ0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nanosecond+pulsed+electric+field+%28nsPEF%29+and+vaccines%3A+a+novel+technique+for+the+inactivation+of+SARS-CoV-2+and+other+viruses%3F&rft.jtitle=Annals+of+medicine+%28Helsinki%29&rft.au=Ruiz-Fern%C3%A1ndez%2C+A.+R.&rft.au=Rosemblatt%2C+M.&rft.au=Perez-Acle%2C+T.&rft.date=2022-12-31&rft.pub=Taylor+%26+Francis&rft.issn=0785-3890&rft.eissn=1365-2060&rft.volume=54&rft.issue=1&rft.spage=1749&rft.epage=1756&rft_id=info:doi/10.1080%2F07853890.2022.2087898&rft.externalDBID=0YH&rft.externalDocID=2087898 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0785-3890&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0785-3890&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0785-3890&client=summon |